Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Randomized, Controlled, Evaluator-Blinded Study of the Safety and Effectiveness of Sebacia Microparticles as an Accessory to 1064 nm Nd:Yag Laser in the Treatment of Facial Inflammatory Acne Vulgaris
Conditions
Interventions
Sebacia Microparticles
Nd:Yag Laser
Locations
11
United States
Clear Dermatology & Aesthetics Center
Scottsdale, Arizona, United States
Scripps Health
San Diego, California, United States
Miami Dermatology & Laser Institute
Miami, Florida, United States
Meridian Clinical Research
Savannah, Georgia, United States
MediSearch Clinical Trials
Saint Joseph, Missouri, United States
Dermatology, Laser & Vein Institute
Charlotte, North Carolina, United States
Start Date
September 25, 2017
Primary Completion Date
April 10, 2018
Completion Date
April 10, 2018
Last Updated
October 14, 2019
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Sebacia, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions